TrialInternational journal of cancer2012

Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites.

Marion G Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.